Phase I – Other

1,064 trials 249 recruiting

Filter these 1,064 trials by condition, country, sponsor and more.

Open in Search →

A dosimetry trial of uPAR targeted radioligand therapy in patients with glioblastoma Recruiting

2024-520105-39-00 Glioblastoma 2025-11-25
A Study of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver Impairment Recruiting

2025-521947-19-00 Healthy, Hepatic Insufficiency 2025-11-19
A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, MULTIPLE RISING DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMA… Recruiting

2025-522097-36-00 alopecia areata 2025-11-19
IMAGINE 1 Recruiting

2025-522290-11-00 Cholangiocarcinoma, pancreatic cancer, colo-rectal canc 2025-11-18
Study of GS-0151 in Participants With Rheumatoid Arthritis Recruiting

2024-516520-34-00 Rheumatoid Arthritis 2025-11-17
A Trial to Examine the Effects of MSP-2020 on Brain Activity in Healthy Adults Recruiting

2025-522930-29-00 Incomplete Response - Major Depressive Disorder (IR-MDD 2025-11-17
Psilocybin's effects on anhedonia Recruiting

2024-519265-22-00 Major Depressive Disorder 2025-11-12
A 52-week, Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of Siplizumab in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (A… Recruiting

2023-506174-12-00 Amyotrophic Lateral Sclerosis 2025-11-06
A SINGLE-ARM, OPEN-LABEL, PHASE I STUDY TO DETERMINE THE SAFETY, TOLERABILITY, AND PRELIMINARY EFFICACY OF OBE-CEL IN PARTICIPANTS WITH REFR… Recruiting

2024-519552-93-00 Refractory Progressive Multiple Sclerosis 2025-11-03
OMTX705-006 Phase 1b Recruiting

2025-521872-69-00 Advanced/Metastatic Pancreatic Adenocarcinoma 2025-10-28
A phase 1, Pharmacokinetic Comparison of Vonafexor Acid and Its Lysine Salt (EYP651) and Evaluation of Potential Drug-Drug Interactions. Recruiting

2025-522915-40-00 Healthy volunteers, Impaired renal function and suspect 2025-10-28
A trial to determine the dose, and evaluate the safety and pharmacokinetics of lutetium Lu 177 edotreotide in children with somatostatin rec… Recruiting

2024-512831-66-00 Pediatric participants aged two to less than 18 years o 2025-10-24
Study of IADADEMSTAT for the Treatment of Sickle Cell Disease. Recruiting

2025-521838-29-00 Sickle Cell Disease 2025-10-16
A research study looking at how different doses of study medicine (Inno8) work in the body of people with haemophilia A Recruiting

2025-520490-38-00 Haemophilia A with or without inhibitors. Proposed indi 2025-10-13
Examining the effects of intravenous oxytocin infusion on peripheral sensory afferents using microneurography technique in healthy volunteer… Recruiting

2024-519670-39-00 Healthy participants 2025-10-13
A Study to Evaluate the Effect of TRIV-509 on Skin Barrier Function in Patients with Atopic Dermatitis. Recruiting

2025-522635-34-00 Atopic Dermatitis 2025-10-09
A Study to Test How Safe, Effective and How Body’s Responds to the Combination of Mosunetuzumab and Pirtobrutinib Together to Treat Patients… Recruiting

2024-514152-32-00 Relapsed or Refractory Chronic Lymphocytic Leukemia (R/ 2025-10-06
A dose-finding Phase I study of F8IL10 intra-articular treatment in Rheumatoid Arthritis Recruiting

2024-517896-19-00 Patients with Rheumatoid Arthritis (RA) who, despite tr 2025-09-29
A Phase 1 study of GSK5764227 in participants with advanced solid tumors Recruiting

2024-513663-10-01 Neoplasms 2025-09-17
Evaluation of safety, side effects and how the drug CHF6467 administrated via intranasal route is absorbed, modified and removed in healthy … Recruiting

2025-521455-23-00 Neonatal Hypoxic-Ischemic Encephalopathy (HIE) 2025-09-11
Effects of opioid-free multimodal anesthesia on functional neuroimaging and electroencephalogram Recruiting

2024-520157-20-00 healthy volunteers undergoing induced sedation 2025-09-09
Phase I, Open-Label Study to Evaluate the Pharmacokinetics, Safety and Tolerability of BIA 28-6156 in Participants with Varying Degrees of R… Recruiting

2025-520754-11-00 Parkinson's disease 2025-08-25
A Trial to Evaluate Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Insulin GZR4 Compared with Insulin Degludec and Insulin … Recruiting

2025-522662-67-00 Type 2 Diabetes Mellitus 2025-08-13
CO2 challenge study of NTX-1955 in healthy participants Recruiting

2025-522281-68-00 Generalized Anxiety Disorder (GAD) 2025-08-08